In order to achieve some uniformity in histological detection of bone marrow infiltration by neuroblastoma and to provide a measure of variation in histological opinions, sections from 712 evaluable trephine biopsy cores from children in a European Neuroblastoma Study Group (ENSG) study were reviewed centrally. Biopsy specimens were graded as tumour positive or negative. Discordance between local and central review opinions was found in 5% of specimens. Only five of 165 children at presentation and nine of 256 re-staging procedures in 126 children, affecting one child each, had their diagnosis upgraded to positive. In six re-staging procedures, affecting one child each, the diagnosis was downgraded. The low discordance rate is encouraging and substantially less important than previously documented difficulties in obtaining adequate specimens. (J Clin Pathol 1996;49:691-692) Keywords: bone marrow trephine biopsy, children, neuroblastoma.
Bone marrow trephine biopsy, in addition to aspiration, is frequently part of the assessment of children with neuroblastoma. No centrally reviewed study of histological diagnoses from such biopsy specimens has been published. We report a large series of bone marrow biopsy specimens from children with neuroblastoma in which sections from all cores have been reviewed centrally. The purpose of the review process was to achieve some uniformity of histological opinion in children entered into European Neuroblastoma Study Group (ENSG) therapeutic trials, but it also provided the first opportunity to obtain some measure of the extent of variation in those opinions in a large series. Numbers of positive and negative cores were determined and for each core the reviewers' opinion was compared with that of the local pathologist in order that discordance rates could be calculated. For convenience, discordant results were described as false positive or false negative with no intention to beg the question about the right answer. Therefore, no formal calculation of sensitivity or specificity of local pathologists' reports was made. For each discordant result the impact of the change on the final histological diagnosis of the staging or re-staging procedure was determined. Results were grouped into those from presentation and those after treatment had started. Many children had more than one biopsy specimen taken during each staging or re-staging procedure, and many were re-staged more than once.
Results
Sections from 712 evaluable biopsy cores from 26 participating centres were graded. Table 1 summarises the results. As expected, most cores at presentation contained tumour while most after treatment had started did not. The discordance rate in both groups is approximately 5%.
In only five of 165 children at presentation was tumour missed by the local pathologist and the histological diagnosis of the staging procedure upgraded to positive. The other eight false negative biopsy specimens were accompanied by another from the same child with locally detected tumour and therefore did not affect the staging. The single false positive biopsy specimen at presentation was from a child with an accompanying, infiltrated biopsy. Changing the result to negative did not affect the staging. Of 256 post-treatment, re-staging procedures the final histological diagnosis was upgraded in nine, and downgraded in six. In each case a different child was affected. The remaining five discordant, post-treatment results did not affect the staging. The reviewers thus disagreed with the local histological opinion in only 3% of presentation and 6% of post- Reid, Roald rest on it alone. This low rate of discordance is therefore probably acceptable and unlikely to be improved on. In order to demonstrate convincingly a reduction in the discordance rate to 2.5% we would need to analyse at least 500 more staging/re-staging procedures.
Only crude, positive/negative assessments were analysed because, in effect, that is all that is required by current ENSG studies and internationally agreed criteria.3 Our study indicates that pathologists in the participating centres use similar, albeit sometimes ill defined and subjective, criteria to detect tumour. Other more subtle abnormalities such as abnormal architecture and pattern of fibrous tissue4 were also recorded by the reviewers. When the study is mature it may be possible to decide whether such abnormalities are clinically important. Should this be the case some reappraisal of the purpose of and need for central review may be necessary. Currently, the inadequate biopsy rate (average 17%) and its variation between centres' is a substantially larger problem than differences in histological opinions about the presence or absence of tumour in the specimens.
